Meningitis vaccine approved for California college

Health officials at a Southern California college will start offering a vaccine against bacterial meningitis after an outbreak in November.

Officials at the University of California, Santa Barbara said Friday that federal health regulators have approved the vaccine for use on campus. The vaccine is approved for use overseas but is not yet approved for general use in the United States.

The move comes after Princeton University last year received permission to dole out the after eight students became infected.

Four students at Santa Barbara fell ill in November. Three recovered and the fourth had both feet amputated. No new cases have been diagnosed.

Meningococcal disease can be spread among people in dormitories and other crowded settings.

The university plans to hold a two-week vaccination clinic in late February.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Princeton vaccine reaches 90 percent of eligible

Dec 13, 2013

Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Recommended for you

EU regulator: Morning-after pill OK for all women

10 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

14 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

15 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments